This study is testing whether adding a focused ultrasound treatment called Suizenji to standard chemotherapy helps people with advanced pancreatic cancer that cannot be surgically removed. It is for patients whose cancer did not respond well to or who could not tolerate their fir…
Phase: NA • Sponsor: SONIRE Therapeutics Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC